IBDEI040 ; ; 09-FEB-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4879,0)
 ;;=C84.68^^22^216^55
 ;;^UTILITY(U,$J,358.3,4879,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4879,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4879,1,4,0)
 ;;=4^C84.68
 ;;^UTILITY(U,$J,358.3,4879,2)
 ;;=^5001659
 ;;^UTILITY(U,$J,358.3,4880,0)
 ;;=C84.69^^22^216^56
 ;;^UTILITY(U,$J,358.3,4880,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4880,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4880,1,4,0)
 ;;=4^C84.69
 ;;^UTILITY(U,$J,358.3,4880,2)
 ;;=^5001660
 ;;^UTILITY(U,$J,358.3,4881,0)
 ;;=C84.70^^22^216^37
 ;;^UTILITY(U,$J,358.3,4881,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4881,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Unspec Site
 ;;^UTILITY(U,$J,358.3,4881,1,4,0)
 ;;=4^C84.70
 ;;^UTILITY(U,$J,358.3,4881,2)
 ;;=^5001661
 ;;^UTILITY(U,$J,358.3,4882,0)
 ;;=C84.71^^22^216^38
 ;;^UTILITY(U,$J,358.3,4882,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4882,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4882,1,4,0)
 ;;=4^C84.71
 ;;^UTILITY(U,$J,358.3,4882,2)
 ;;=^5001662
 ;;^UTILITY(U,$J,358.3,4883,0)
 ;;=C84.72^^22^216^39
 ;;^UTILITY(U,$J,358.3,4883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4883,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4883,1,4,0)
 ;;=4^C84.72
 ;;^UTILITY(U,$J,358.3,4883,2)
 ;;=^5001663
 ;;^UTILITY(U,$J,358.3,4884,0)
 ;;=C84.73^^22^216^40
 ;;^UTILITY(U,$J,358.3,4884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4884,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4884,1,4,0)
 ;;=4^C84.73
 ;;^UTILITY(U,$J,358.3,4884,2)
 ;;=^5001664
 ;;^UTILITY(U,$J,358.3,4885,0)
 ;;=C84.74^^22^216^41
 ;;^UTILITY(U,$J,358.3,4885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4885,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4885,1,4,0)
 ;;=4^C84.74
 ;;^UTILITY(U,$J,358.3,4885,2)
 ;;=^5001665
 ;;^UTILITY(U,$J,358.3,4886,0)
 ;;=C84.75^^22^216^42
 ;;^UTILITY(U,$J,358.3,4886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4886,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4886,1,4,0)
 ;;=4^C84.75
 ;;^UTILITY(U,$J,358.3,4886,2)
 ;;=^5001666
 ;;^UTILITY(U,$J,358.3,4887,0)
 ;;=C84.76^^22^216^43
 ;;^UTILITY(U,$J,358.3,4887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4887,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4887,1,4,0)
 ;;=4^C84.76
 ;;^UTILITY(U,$J,358.3,4887,2)
 ;;=^5001667
 ;;^UTILITY(U,$J,358.3,4888,0)
 ;;=C84.77^^22^216^44
 ;;^UTILITY(U,$J,358.3,4888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4888,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Spleen
 ;;^UTILITY(U,$J,358.3,4888,1,4,0)
 ;;=4^C84.77
 ;;^UTILITY(U,$J,358.3,4888,2)
 ;;=^5001668
 ;;^UTILITY(U,$J,358.3,4889,0)
 ;;=C84.78^^22^216^45
 ;;^UTILITY(U,$J,358.3,4889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4889,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4889,1,4,0)
 ;;=4^C84.78
 ;;^UTILITY(U,$J,358.3,4889,2)
 ;;=^5001669
 ;;^UTILITY(U,$J,358.3,4890,0)
 ;;=C84.79^^22^216^46
 ;;^UTILITY(U,$J,358.3,4890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4890,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Negative,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4890,1,4,0)
 ;;=4^C84.79
 ;;^UTILITY(U,$J,358.3,4890,2)
 ;;=^5001670
 ;;^UTILITY(U,$J,358.3,4891,0)
 ;;=C84.A0^^22^216^113
 ;;^UTILITY(U,$J,358.3,4891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4891,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,4891,1,4,0)
 ;;=4^C84.A0
 ;;^UTILITY(U,$J,358.3,4891,2)
 ;;=^5001681
 ;;^UTILITY(U,$J,358.3,4892,0)
 ;;=C84.A1^^22^216^106
 ;;^UTILITY(U,$J,358.3,4892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4892,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4892,1,4,0)
 ;;=4^C84.A1
 ;;^UTILITY(U,$J,358.3,4892,2)
 ;;=^5001682
 ;;^UTILITY(U,$J,358.3,4893,0)
 ;;=C84.A2^^22^216^110
 ;;^UTILITY(U,$J,358.3,4893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4893,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4893,1,4,0)
 ;;=4^C84.A2
 ;;^UTILITY(U,$J,358.3,4893,2)
 ;;=^5001683
 ;;^UTILITY(U,$J,358.3,4894,0)
 ;;=C84.A3^^22^216^108
 ;;^UTILITY(U,$J,358.3,4894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4894,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4894,1,4,0)
 ;;=4^C84.A3
 ;;^UTILITY(U,$J,358.3,4894,2)
 ;;=^5001684
 ;;^UTILITY(U,$J,358.3,4895,0)
 ;;=C84.A4^^22^216^104
 ;;^UTILITY(U,$J,358.3,4895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4895,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4895,1,4,0)
 ;;=4^C84.A4
 ;;^UTILITY(U,$J,358.3,4895,2)
 ;;=^5001685
 ;;^UTILITY(U,$J,358.3,4896,0)
 ;;=C84.A5^^22^216^107
 ;;^UTILITY(U,$J,358.3,4896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4896,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4896,1,4,0)
 ;;=4^C84.A5
 ;;^UTILITY(U,$J,358.3,4896,2)
 ;;=^5001686
 ;;^UTILITY(U,$J,358.3,4897,0)
 ;;=C84.A6^^22^216^109
 ;;^UTILITY(U,$J,358.3,4897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4897,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4897,1,4,0)
 ;;=4^C84.A6
 ;;^UTILITY(U,$J,358.3,4897,2)
 ;;=^5001687
 ;;^UTILITY(U,$J,358.3,4898,0)
 ;;=C84.A7^^22^216^112
 ;;^UTILITY(U,$J,358.3,4898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4898,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Spleen
 ;;^UTILITY(U,$J,358.3,4898,1,4,0)
 ;;=4^C84.A7
 ;;^UTILITY(U,$J,358.3,4898,2)
 ;;=^5001688
 ;;^UTILITY(U,$J,358.3,4899,0)
 ;;=C84.A8^^22^216^111
 ;;^UTILITY(U,$J,358.3,4899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4899,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4899,1,4,0)
 ;;=4^C84.A8
 ;;^UTILITY(U,$J,358.3,4899,2)
 ;;=^5001689
 ;;^UTILITY(U,$J,358.3,4900,0)
 ;;=C84.A9^^22^216^105
 ;;^UTILITY(U,$J,358.3,4900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4900,1,3,0)
 ;;=3^Cutaneous T-Cell Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4900,1,4,0)
 ;;=4^C84.A9
 ;;^UTILITY(U,$J,358.3,4900,2)
 ;;=^5001690
 ;;^UTILITY(U,$J,358.3,4901,0)
 ;;=C84.Z0^^22^216^320
 ;;^UTILITY(U,$J,358.3,4901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4901,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Unspec Site
 ;;^UTILITY(U,$J,358.3,4901,1,4,0)
 ;;=4^C84.Z0
 ;;^UTILITY(U,$J,358.3,4901,2)
 ;;=^5001691
 ;;^UTILITY(U,$J,358.3,4902,0)
 ;;=C84.Z1^^22^216^314
 ;;^UTILITY(U,$J,358.3,4902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4902,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4902,1,4,0)
 ;;=4^C84.Z1
 ;;^UTILITY(U,$J,358.3,4902,2)
 ;;=^5001692
 ;;^UTILITY(U,$J,358.3,4903,0)
 ;;=C84.Z2^^22^216^318
 ;;^UTILITY(U,$J,358.3,4903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4903,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,4903,1,4,0)
 ;;=4^C84.Z2
 ;;^UTILITY(U,$J,358.3,4903,2)
 ;;=^5001693
 ;;^UTILITY(U,$J,358.3,4904,0)
 ;;=C84.Z3^^22^216^316
 ;;^UTILITY(U,$J,358.3,4904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4904,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,4904,1,4,0)
 ;;=4^C84.Z3
 ;;^UTILITY(U,$J,358.3,4904,2)
 ;;=^5001694
 ;;^UTILITY(U,$J,358.3,4905,0)
 ;;=C84.Z4^^22^216^312
 ;;^UTILITY(U,$J,358.3,4905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4905,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,4905,1,4,0)
 ;;=4^C84.Z4
 ;;^UTILITY(U,$J,358.3,4905,2)
 ;;=^5001695
 ;;^UTILITY(U,$J,358.3,4906,0)
 ;;=C84.Z5^^22^216^315
 ;;^UTILITY(U,$J,358.3,4906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4906,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,4906,1,4,0)
 ;;=4^C84.Z5
 ;;^UTILITY(U,$J,358.3,4906,2)
 ;;=^5001696
 ;;^UTILITY(U,$J,358.3,4907,0)
 ;;=C84.Z6^^22^216^317
 ;;^UTILITY(U,$J,358.3,4907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4907,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,4907,1,4,0)
 ;;=4^C84.Z6
 ;;^UTILITY(U,$J,358.3,4907,2)
 ;;=^5001697
 ;;^UTILITY(U,$J,358.3,4908,0)
 ;;=C84.Z8^^22^216^319
 ;;^UTILITY(U,$J,358.3,4908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4908,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,4908,1,4,0)
 ;;=4^C84.Z8
 ;;^UTILITY(U,$J,358.3,4908,2)
 ;;=^5001699
 ;;^UTILITY(U,$J,358.3,4909,0)
 ;;=C84.Z9^^22^216^313
 ;;^UTILITY(U,$J,358.3,4909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4909,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,4909,1,4,0)
 ;;=4^C84.Z9
 ;;^UTILITY(U,$J,358.3,4909,2)
 ;;=^5001700
 ;;^UTILITY(U,$J,358.3,4910,0)
 ;;=C84.90^^22^216^311
 ;;^UTILITY(U,$J,358.3,4910,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4910,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas Unspec,Unspec Site
 ;;^UTILITY(U,$J,358.3,4910,1,4,0)
 ;;=4^C84.90
 ;;^UTILITY(U,$J,358.3,4910,2)
 ;;=^5001671
 ;;^UTILITY(U,$J,358.3,4911,0)
 ;;=C84.91^^22^216^304
 ;;^UTILITY(U,$J,358.3,4911,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4911,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas Unspec,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,4911,1,4,0)
 ;;=4^C84.91
 ;;^UTILITY(U,$J,358.3,4911,2)
 ;;=^5001672
 ;;^UTILITY(U,$J,358.3,4912,0)
 ;;=C84.92^^22^216^306
 ;;^UTILITY(U,$J,358.3,4912,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4912,1,3,0)
 ;;=3^Mature T/NK-Cell Lymphomas Unspec,Intrathoracic Nodes
